Plus therapeutics to present at the h.c. wainwright global investment conference

Austin, texas, sept. 08, 2021 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that marc h. hedrick m.d., president and chief executive officer of plus therapeutics, will present a company overview at the h.c. wainwright 23rd annual global investment conference being held virtually september 13 – 15, 2021.
pstv Ratings Summary
pstv Quant Ranking